Euclises Pharmaceuticals, Inc.

City:

St. Louis, Missouri

Country:

United States

Published Applications:

Last publication date:

2016-11-24

Patent Grants:

Last grant date:

2019-04-23

Top Inventors for applications by Euclises Pharmaceuticals, Inc.

These are the the leading inventors for applications assigned to Euclises Pharmaceuticals, Inc.:

Eduardo J. Martinez 3 Bryn Mawr, PA United States
John J. Talley 3 St. Louis, MO United States
Terri L. Boehm 2 Ballwin, MO United States
Kevin D. Jerome 1 St. Charles, MO United States

Recent patent applications by Euclises Pharmaceuticals, Inc.

Euclises Pharmaceuticals, Inc. based in St. Louis, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2016-11-24 ✅ Patent 10,266,511 granted on 2019-04-23

US20160340330A1

Chemistry; metallurgy

No-releasing nitrooxy-chromene conjugates

#2 | 2014-01-16 ✅ Patent 8,859,781 granted on 2014-10-14

US20140018544A1

Chemistry; metallurgy

No-releasing nonoate(nitrogen-bound)sulfonamide-linked-coxib anti-cancer agents

#3 | 2014-01-16 ✅ Patent 9,044,464 granted on 2015-06-02

US20140018403A1

Human necessities

No-releasing guanidine-coxib anti-cancer agents

Also check out Euclises Pharmaceuticals, Inc.'s (St. Louis, United States) applicant profile with 3 patent applications submitted.

AssigneeID:

485158 ⎘